Hi, help us enhance your experience
Hi, help us enhance your experience
Hi, help us enhance your experience
2172 Views
Dr KK Aggarwal 17 February 2020
CMAAO Update 16th February on COVID-19
Authors: Dr K K Aggarwal, Dr Rajan Sharma, Dr R V Asokan, Dr KK Kalra, Dr Sushil Kumar, Dr Anita Arora, Dr Upasana Arora, Dr SS Srivastava, Dr Shilpi Khanna, Ms Swati, Dr Rahiul Shukla, Dr Arti Verma, Dr Anil Kumar, DSr G S Gyani, Dr Sonal Saxena, DSr CM Bhagat, Dr Vikas Manchanda, Dr Nandani Sharma, Dr Suneela Garg, Dr TK Joshi, Dr Mamta Jajoo, Dr Shariga Qureshi, Dr Manish Kumar, Dr Harmeet Singh, Dr Dr Rai, Dr VK Monga, Dr AP Singh, Dr Ramesh Datta, Dr Maj Prachi Garg, Dr Anil Kumar, Dr Rajni, Dr Rajeev Kumar, Dr Harish Grover, Dr Mini Mehta, Dr Lalan Bharti, ( More to be added)
Summary
COVID-19 virus possibly behaves like SARS; causes mild illness in 82%, severe illness in 15%, critical illness in 3% and death in 2% cases ( 15% of admitted serious cases, 71% with comorbidity); affects all ages but predominantly males (56%) with median age 59 years (2-74 years, less in children below 15); with mean incubation period 5.2 days (2-214 days); mean time to symptoms 5 days, mean time to pneumonia 9 days, mean time to death 14 days, 3-4 reproductive number R0 ( flu 1.2 and SARS 2); epidemic doubling time 7.5 days; has origin possibly from bats; spreads via large droplets and predominately from people having lower respiratory infections and hence standard droplet precautions are the answer for the public and close contacts and airborne precautions for healthcare workers dealing with the secretions.
Clinically all patients have fever, 75% have cough; 50% weakness; 50% breathlessness with low total white count and deranged liver enzymes. About 20% need ICU care and 15% of them are fatal.
Close Contacts are defined as healthcare-associated exposure, which includes providing direct care for COVID-19 patients, working with health care workers infected with COVID-19, visiting patients or staying in the same close environment of a COVID-19 patient OR working together in close proximity or sharing the same classroom environment with a with COVID-19 patient OR traveling together with COVID-19 patient OR Living in the same household as a COVID-19 patient OR the epidemiological link may have occurred within a 14-day period before or after the onset of illness in the case under consideration.
New updates
Daily Statistics 15th February, 29 countries
Total cases: 71329
New cases yesterday: 2008
Deaths: 1,775
Recovered: 10973 (86%)
Currently Infected Patients: 58581
Mild cases: 47282 (81%)
Serious or Critical: 11,298 (19%)
Deaths yesterday: 105
Serious or critical mortality 15%
Likely minimum deaths 1775 +1695 = 3470 with the present trend and available treatment (plus deaths linked to daily new cases)
Around the globe
February 17:
February 16:
1,933 new cases
100 new deaths
58,182 cumulative total cases
6,639 cumulative total hospital discharges
40,814 currently hospitalized, of which:
- 31,007 (76.0%) mild
- 8,024 (19.7%) serious
- 1,773 (4.3%) critical
1,016 new hospital discharges
191,434 close contacts tracked
Travel Restrictions
Travel advisory: Level 1 in all countries (Exercise normal standard hygiene precautions), Level 2 in all affected countries and states including Kerala (Exercise a high degree of caution), Level 3 in all countries with secondary cases (Reconsider your need to travel), done by India, and Level 4 (Do not travel), done by US. Hong Kong has imposed 14 days quarantine on people arriving from China. The Karnataka government has ordered that anybody arriving from the 23 COVID-19-affected countries must stay in isolation at home for 28 days. The home isolation requirement is irrespective of the virus symptoms. To date, 72 countries have implemented travel restrictions.
Travel preferable seat: Choosing a window seat and staying there lowers the risk
Travel and trade restrictions: WHO says no to countries
Leave China all together: UK, condemned by many countries
Entry to India not allowed: Foreigners who went to China on or after January 15
Visas Suspended: All visas issued to Chinese nationals before February 5 (not applicable to aircrew)
Flight suspended: IndiGo and Air India have suspended all of their flights between the two countries. SpiceJet continues to fly on Delhi-Hong Kong route.Evacuation
Many countries including US, Japan, India have evacuated their citizens.
Case fatality
COVID-19 2%; MERS 34% (2012, killed 858 people out of the 2,494 infected); SARS 10% (Nov. 2002 - Jul. 2003, originated from Beijing, spread to 29 countries, with 8,096 people infected and 774 deaths); Ebola 50%; Smallpox 30-40%; Measles 10-15% developing countries; Polio 2-5% children and 15-30% adults; Diphtheria 5-10%; Whooping cough 4% infants < 1yr, 1% children < 4 years; Swine flu < 0.1-4 %; Seasonal flu 0.01%; COVID19 in Wuhan 4.9%; COVID-19 in Hubei Province 3.1%; COVID19 Nationwide 2.1%; COVID19 in other provinces 0.16%.
Number of flu deaths every year: 290,000 to 650,000 (795 to 1,781 deaths per day)
Public Health Emergency of International Concern - 30th January, 2020
Mandatory to report to WHO each human and animal case.
Prior 5 PHEICs:
26th April 2009 Swine flu: 10 August 2010, WHO announced that the H1N1 influenza virus has moved into the post-pandemic period. However, localized outbreaks of various magnitudes are likely to continue.
May 2014 Polio: resurgence of wild polio. October 2019, continuing cases of wild polio in Pakistan and Afghanistan, in addition to new vaccine-derived cases in Africa and Asia; the status was reviewed and it remains a PHEIC. It was extended on 11 December, 2019.
August 2014 Ebola: It was the first PHEIC in a resource-poor setting.
Feb 1 2016 Zika: link with microcephaly and Guillain–Barré syndrome. This was the first time a PHEIC was declared for a mosquito‐borne disease. This declaration was lifted on 18 November 2016.
2018–20 Kivu Ebola: A review of the PHEIC had been planned at the fifth meeting of the EC on 10 October 2019 and as of 18 October 2019, it continues to be a PHEIC.
Kerala: State public health emergency. Three primary cases in North, South and Central - Kasaragod district in north Kerala, Thrissur in central Kerala and Alappuzha in South Kerala. Four Karnataka districts bordering Kerala — Kodagu, Mangaluru, Chamarajanagar and Mysuru - have been put on high alert.
About the Virus
Single-strand, positive-sense RNA genome ranging from 26 to 32 kilobases in length, Beta corona virus from Corona family.
‘Corona’ means crown or the halo around the sun. Heart is considered crown and hence the arteries that supply oxygen to the heart are also called coronary arteries. Under an electron microscope, is the virus appears round with spikes poking out from its periphery.
Three deadly human respiratory coronaviruses: Severe acute respiratory syndrome coronavirus [SARS-CoV], Middle East respiratory syndrome coronavirus [MERS-CoV]) and COVID 19: The current virus is 75-80% identical to the SARS-CoV
Origin: Wuhan, China December 2019. 1st case informed to the world by Dr. Li Wenliang; died Feb 6.
The virus is likely to be killed by sunlight, temperature, and humidity. SARS stopped around May and June in 2003 probably due to more sunlight and more humidity. Alive on surface: possibly 3-12 hours.
Link to ACE: COVID-19 might be able to bind to the angiotensin-converting enzyme 2 receptor in humans.
Pathogenesis
High viral load: Detection of COVID-19 RNA in specimens from the upper respiratory tract with low Ct values on day 4 and day 7 of illness suggests high viral loads and potential for transmissibility. [NEJM]
COVID-19 uses the same cellular receptor as SARS-CoV (human angiotensin-converting enzyme 2 [hACE2]), so transmission is expected only after signs of lower respiratory tract disease develop.
SARS is high [unintelligible] kind of inducer. This means that when it infects the lower part of the lung, the body develops a very severe reaction against it and leads to lots of inflammation and scarring. In SARS, after the first 10 to 15 days, it wasn’t the virus killing the patients it was the body’s reaction. Is this virus in the MERS or SARS kind picture or is this the other type of virus which is a milder coronavirus like the NL63 or the 229? It may be the mild (unintelligible) kind of inducer. [Dr John Nicholls, University of Hong Kong]
COVID-19 seems to thrive better in primary human airway epithelial cells as compared to standard tissue-culture cells, unlike SARS-CoV or MERS-CoV. COVID-19 will likely behave more like SARS-CoV.
SARS-CoV and MERS-CoV affect the intrapulmonary epithelial cells more than cells of the upper airways. Transmission thus occurs primarily from patients with recognized illness and not from patients with mild, nonspecific signs. However, NEJM has reported a case of COVID-19 infection acquired outside of Asia wherein transmission occurred during the incubation period in the index patient, but the same has been challenged now.
This new virus attacks the lungs as well, and not just the throat. Patients so far have not presented with a sore throat, because COVID-19 attacks the intraepithelial cells of lung tissue.
Transmission
Zoonotic and linked to Huanan Seafood Wholesale Market as 55% with onset before January 1, 2020 originated there vs. only 8.6% of the subsequent cases. The Chinese government has banned wildlife trade until the epidemic passes.
This new coronavirus is closely related to bat coronaviruses. Bats are the primary reservoir. While SARS-CoV was transmitted to humans from exotic animals in wet markets, MERS-CoV transmitted from camels. The ancestral hosts were probably bats; however.
The virus has been traced to snakes in China. Snakes often hunt for bats. According to reports, snakes were sold in the local seafood market in Wuhan, thus raising the likelihood that COVID 19 might have moved from the host species, i.e., bats, to snakes and then to humans. It is still not understood as to how the virus could adapt to both the cold-blooded and warm-blooded hosts.
It cannot be transmitted by eating wild animals as it is a respiratory secretions disease.
It transmits predominantly via droplets, like common flu and not like airborne illnesses (TB, Measles, Chickenpox).
Kissing scenes have been banned in movies in China. In Kerala, air crew have been exempted from breath analyser tests and China has banned death ceremonies, people gathering together. NEJM reported a small cluster of five cases suggesting transmission from asymptomatic individuals during the incubation period; all patients in this cluster had mild illness. But the same has been challenged. Another case got infected while using gown, but eyes uncovered.
Serious illnesses in other countries are less as patients with breathlessness are unlikely to board and patients will mild illness or asymptomatic illness are less likely to transmit infections. NEJM reports of a taxi driver infected with SARS-CoV-2 in Thailand, potentially from Chinese tourists; the infection appears not to have spread to others.
Legal Implications India: Section 270 in the Indian Penal Code: 270. Malignant act likely to spread infection of disease dangerous to life.—Whoever malignantly does any act which is, and which he knows or has reason to believe to be, likely to spread the infection of any disease dangerous to life, shall be punished with imprisonment of either description for a term which may extend to two years, or with fine, or with both.
Quarantine has Limitations
China has imposed quarantines across Hubei province, locking in about 56 million people, in an attempt to stop it from spreading. Millions of others cities far from the epicenter are also enduring travel restrictions.
Villages in Vietnam with 10,000 people close to the nations capital have also been placed under quarantine after six cases of the deadly coronavirus were identified there. The locking down of the commune of Son Loi, about 40 kilometres from Hanoi, is the first mass quarantine outside of China since the virus emerged from central China late last year.
Standard Respiratory Droplets Precautions
At triage: Surgical 3 layered mask to the patient; Isolation of at least 1m distance, cough etiquette and hand hygiene
Droplet precautions: Three layer surgical mask by patients, their contacts and health care workers, in an adequately ventilated isolation room, health care workers while caring with the secretions should use eye protection, face shields/goggles. One should limit patient movement, restrict attendants and observe hand hygiene.
Contact precautions: When entering room - gown, mask, goggles, gloves – remove before leaving the room; Dedicated equipment/disinfection after every use; Care for environment- door knobs, handles, articles, laundry; Avoid patient transport and practice hand hygiene.
Airborne precautions when handling virus in the lab and while performing aerosol-generating procedures. Room should be with negative pressure with minimum of 12 air changes per hour or at least 160 litres/second/patient in facilities with natural ventilation. There should be restricted movement of other people and all should use gloves, long-sleeved gowns, eye protection, and fit-tested particulate respirators (N95 or equivalent, or higher level of protection)
Public
Strict self-quarantine if sick with flu like illness: 2 weeks
Wash your hands often and for at least 20 seconds with soap and water or use an alcohol-based hand sanitizer.
Avoid touching: Eyes, nose, and mouth with unwashed hands.
Avoid close contact: (3-6 feet) with people who are sick with cough or breathlessness
Cover your cough or sneeze with a tissue, then throw the tissue in the trash.
Clean and disinfect frequently touched objects and surfaces.
Masks
Surgical 3 layered Masks: For patients and close contacts
N 95 Masks: For health care providers when handling respiratory secretions.
Lab tests
Treatment
Case Definitions
Case Definitions
Suspect case
Probable case
A suspect case for whom testing for COVID 19 is inconclusive or for whom testing was positive on a pan-coronavirus assay.
Confirmed case
A person with laboratory confirmation of COVID 19 infection, irrespective of clinical signs and symptoms.
Severe acute respiratory infection (SARI)
An ARI with history of fever or measured temperature ≥38 C° and cough; onset within the last ~10 days; and requiring hospitalization. Absence of fever does NOT exclude viral infection
SARI in a person, with history of fever and cough requiring hospital admission, with no other etiology that can fully explain the clinical presentation (clinicians should also be alert to the possibility of atypical presentations in immunocompromised patients)
AND any of the following:
OR A person with acute respiratory illness of any severity who, within 14 days before onset of illness, had any of the following exposures:
Uncomplicated illness
Patients with uncomplicated upper respiratory tract viral infection, may have non- specific symptoms such as fever, cough, sore throat, nasal congestion, malaise, headache, muscle pain or malaise. The elderly and immunosuppressed may present with atypical symptoms. These patients have no signs of dehydration, sepsis or shortness of breath
Mild pneumonia
Patient with pneumonia and no signs of severe pneumonia. Child has cough or difficulty breathing + fast breathing: fast breathing (in breaths/min): <2 months, ≥60; 2–11 months, ≥50; 1–5 years, ≥40 and no signs of severe pneumonia
Severe pneumonia
Adolescent or adult: fever or suspected respiratory infection, AND one of respiratory rate >30 breaths/min, severe respiratory distress, or SpO2 <90% on room air
Child: cough or difficulty in breathing, AND at least one of the following: central cyanosis or SpO2 <90%; severe respiratory distress (e.g. grunting, very severe chest indrawing); signs of pneumonia with a general danger sign: inability to breastfeed or drink, lethargy or unconsciousness, or convulsions. Other signs of pneumonia may be seen: chest indrawing, fast breathing (in breaths/min): <2 months, ≥60; 2–11 months, ≥50; 1–5 years, ≥40.
Diagnosis is clinical; chest imaging can help exclude complications.
Acute Respiratory Distress Syndrome
Onset: new or worsening respiratory symptoms within a week of known clinical insult.
Chest imaging: bilateral opacities, not fully explained by effusions, lobar or lung collapse, or nodules.
Origin of edema: respiratory failure not fully explained by cardiac failure or fluid overload. Need objective assessment (e.g. echocardiography) to exclude hydrostatic cause of edema if no risk factor present.
Oxygenation (adults):
Mild ARDS: 200 mmHg < PaO2/FiO2 ≤ 300 mmHg (with PEEP or CPAP ≥5 cm H2O, or non-ventilated)
Moderate ARDS: 100 mmHg < PaO2/FiO2 ≤200 mmHg with PEEP ≥5 cm H2O, or non-ventilated)
Severe ARDS: PaO2/FiO2 ≤ 100 mmHg with PEEP ≥5 cmH2O, or non- ventilated)
PaO2 not available: SpO2/FiO2 ≤315 suggests ARDS (including in non-ventilated patients)
Oxygenation (children; OI = Oxygenation Index and OSI = Oxygenation Index using SpO2)
Bilevel NIV or CPAP ≥5 cmH2O via full face mask: PaO2/FiO2 ≤ 300 mmHg or SpO2/FiO2 ≤264
Mild ARDS (invasively ventilated): 4 ≤ OI < 8 or 5 ≤ OSI < 7.5 Moderate ARDS (invasively ventilated): 8 ≤ OI < 16 or 7.5 ≤ OSI < 12.3
Severe ARDS (invasively ventilated): OI ≥ 16 or OSI ≥ 12.3
Sepsis
Adults: life-threatening organ dysfunction due to a dysregulated host response to suspected or proven infection, with organ dysfunction.
Signs of organ dysfunction include: altered mental status, difficult or fast breathing, low oxygen saturation, reduced urine output, fast heart rate, weak pulse, cold extremities or low blood pressure, skin mottling, or laboratory evidence of coagulopathy, thrombocytopenia, acidosis, high lactate or hyperbilirubinemia.
Children: suspected or proven infection and ≥2 SIRS criteria; of these, one must be abnormal temperature or white blood cell count
Septic shock
Adults: persisting hypotension despite volume resuscitation, requiring vasopressors to maintain MAP ≥65 mmHg and serum lactate level >2 mmol/L
Children: any hypotension (SBP <5th centile or >2 SD below normal for age) or 2-3 of the following: altered mental state; tachycardia or bradycardia (HR <90 bpm or >160 bpm in infants and HR <70 bpm or >150 bpm in children); prolonged capillary refill (>2 sec) or warm vasodilation with bounding pulses; tachypnea; mottled skin or petechial or purpuric rash; increased lactate; oliguria; hyperthermia or hypothermia
Common Myths
Trolls and conspiracy theories: Not validated and are fake news
Experts Opinions on COVID-19
“I think this virus is probably with us beyond this season, beyond this year, and I think eventually the virus will find a foothold and well get community-based transmission and you can start to think about it like seasonal flu. The only difference is we dont understand this virus”
Dr. Robert Redfield
Director, CDCUS Centers for Disease Control and PreventionFeb. 13, 2020
“What makes this one perhaps harder to control than SARS is that it may be possible to transmit before you are sick. I think we should be prepared for the equivalent of a very, very bad flu season, or maybe the worst-ever flu season in modern times.”
Prof. Marc Lipsitch
Prof. of Epidemiology, Harvard School of Public Health
Head, Harvard Ctr. Communicable Disease Dynamics
Feb. 11, 2020
“I hope this outbreak may be over in something like April’
Prof. Nanshan Zhong
Leading epidemiologist, first to describe SARS coronavirus
Feb. 11, 2020
“It could infect 60% of global population if unchecked”
Prof. Gabriel Leung
Expert on coronavirus epidemics
Chair of Public Health Medicine
Hong Kong University
Feb. 11, 2020
“It’s a new virus. We don’t know much about it, and therefore we’re all concerned to make certain it doesn’t evolve into something even worse”
Prof. W. Ian Lipkin
Epidemiology Director
Columbia University
Feb. 10, 2020
“We are estimating that about 50,000 new infections per day are occurring in China. [...] It will probably peak in its epicenter, Wuhan, in about one-month time; maybe a month or two later in the whole of China. The rest of the world will see epidemics at various times after that.”
Prof. Niall Ferguson
Director, Institute for Disease and Emergency Analytics
Imperial College, London Feb. 6, 2020
“This looks far more like H1N1’s spread than SARS, and I am increasingly alarmed”
Dr. Peter Piot
(Director, The London School of Hygiene and Tropical Medicine)
Feb. 2, 2020
“It sounds and looks as if it’s going to be a very highly transmissible virus [...] This virus may still be learning what it can do, we don’t know its full potential yet.”
Robert Webster
Infectious disease and avian flu expert at St. Jude Children’s Research Hospital
Feb. 2, 2020
“Increasingly unlikely that the virus can be contained”
Dr. Thomas R. Frieden
Former Director of CDC
Feb. 2, 2020
“It’s very, very transmissible, and it almost certainly is going to be a pandemic. But will it be catastrophic? I don’t know “
Dr. Anthony S. Fauci
Director, National Institute of Allergy and Infectious Diseases
Feb. 2, 2020
“Until [containment] is impossible, we should keep trying”
Dr. Mike Ryan
Head of the WHO’s Emergencies Program
Feb. 1, 2020
“The more we learn about it, the greater the possibility is that transmission will not be able to be controlled with public health measures”
Dr. Allison McGeer
Director of Infection Control, Mount Sinai Hospital
Jan. 26, 2020
Confirmed cases and deaths
Country | Cases | Deaths | Region |
China | 70,548 | 1,770 | Asia |
Japan | 414 | 1 | Asia |
Singapore | 75 | 0 | Asia |
Hong Kong | 57 | 1 | Asia |
Thailand | 34 | 0 | Asia |
South Korea | 30 | 0 | Asia |
Malaysia | 22 | 0 | Asia |
Taiwan | 20 | 1 | Asia |
Vietnam | 16 | 0 | Asia |
Germany | 16 | 0 | Europe |
Australia | 15 | 0 | Australia/Oceania |
United States | 15 | 0 | North America |
France | 12 | 1 | Europe |
Macao | 10 | 0 | Asia |
United Arab Emirates | 9 | 0 | Asia |
United Kingdom | 9 | 0 | Europe |
Canada | 8 | 0 | North America |
Philippines | 3 | 1 | Asia |
Italy | 3 | 0 | Europe |
India | 3 | 0 | Asia |
Russia | 2 | 0 | Europe |
Spain | 2 | 0 | Europe |
Belgium | 1 | 0 | Europe |
Nepal | 1 | 0 | Asia |
Finland | 1 | 0 | Europe |
Egypt | 1 | 0 | Africa |
Sweden | 1 | 0 | Europe |
Sri Lanka | 1 | 0 | Asia |
Cambodia | 1 | 0 | Asia |
Role of CMAAO and other Medical Associations
Get prepared for containment, including active surveillance, early detection, isolation and case management, tracking contacts and prevention of spread of the virus and to share full data with WHO. All countries should emphasize on reducing human infection, prevention of secondary transmission and international spread. Intensify IEC activities.
CMAAO IMA FOMA MAMC Recommendations
CMAAO _ Suggestions so far
{{Article_Title}}
{{Article_Author}}
{{Article_Title}}
{{Article_Author}}